Pharmaceutical Organon from Oss at the New York Stock Exchange

The originally Dutch company Organon has been listed on the New York Stock Exchange since this afternoon. With a loss of about 6 percent, trading in the share is not successful in the first hour, but the company is immediately included in the S&P500, the stock index with the five hundred largest publicly traded companies in the United States.

It means that Organon has risen from the ashes. The company was founded almost a hundred years ago and had a large location in Oss. For years it extracted insulin, a drug against diabetes, from the organs of pigs. Later it became known mainly for the contraceptive pill and pregnancy tests.

Until 2007, the drugmaker was part of the chemical group AkzoNobel. In that year Organon was sold to the American multinational Schering-Plough, which is now called MSD. Not long after, that company announced that it would close a large part of the Oss location and that it wanted to lay off thousands of employees. This led to protests in the city.

–